Terry Naturally Curamin Review
#2 of 10 · Best comboReal retailer photo, cut out. Label unedited.
Buy it. Two anti-inflammatory pathways, one bottle, branded actives. BosPure boswellia (5-LOX) + BCM-95 curcumin (NF-κB) + DLPA — two complementary inflammatory pathways in a single, well-reviewed pain formula using standardised branded actives, not commodity powder.
$40 / month$0.33 / tablet (~$1.33 at 4/day)
Why It Scores 8.5 — And The Label Line Behind Each Number
Standardisation to AKBA
35% of scoreUses BosPure, a standardised, AKBA-enriched boswellia, paired with BCM-95 standardised curcumin — branded clinical actives rather than commodity powder. High-precision standardisation on both ingredients. Slightly behind the pure-play AprèsFlex pick only because the boswellia dose is set by the combo formula rather than independently tunable.
Dose alignment with the trial window
25% of scoreAt the full 4-tablet daily dose the formula delivers meaningful, clinical-range amounts of both standardised boswellia and high-absorption curcumin. Both actives land in productive territory. The minor knock: hitting the dose requires four tablets, and the boswellia portion is fixed by the combo rather than separately adjustable to a specific AKBA milligram target.
- Per serving
- Boswellia + curcumin + DLPA + nattokinase (4 tablets/day)
Third-party testing + manufacturing
20% of scoreTerry Naturally's QC is solid and the formula is built on branded, documented standardised actives (BosPure, BCM-95), which carry their own identity and potency characterisation. That branded-material sourcing is itself a meaningful quality signal in an adulteration-prone botanical category.
- Testing
- Terry Naturally QC · branded standardised actives with identity documentation
- Manufacturer
- Terry Naturally (Europharma · flagship natural pain line)
Cost per standardised serving
10% of scoreRoughly $40/month at the 4-tablet dose — the most expensive pick on the list, and a one-month supply per 120-tablet bottle. Defensible because you're buying two branded standardised actives, but as a cost-per-serving line it's the weakest criterion and the reason this isn't a value pick.
- Bottle
- 120 tablets · ~1 month at 4 tablets/day
- Price
- ~$40 / 120-tablet bottle = ~$0.33 per tablet (~$1.33/day at 4 tablets)
Formulation logic
10% of scoreThe strongest formulation logic in the category — it deliberately combines two complementary anti-inflammatory pathways (boswellia's 5-LOX, curcumin's NF-κB) with branded standardised actives. This is exactly the kind of mechanism-aware co-formulation the methodology rewards; full marks.
- Active forms
- BosPure standardised boswellia (AKBA-enriched) + BCM-95 standardised curcumin
- More Specs
- Pathways covered
- 5-LOX (boswellia) + NF-κB (curcumin) — two complementary arms of inflammation
- Co-ingredients
- DLPA (DL-phenylalanine), nattokinase
- Format
- Tablets · 4/day full dose (can split morning/evening with food)
Marketing Claims Vs. Reality
Combines clinically studied BCM-95 curcumin and BosPure boswellia.
Both are real branded standardised actives — BCM-95 a high-absorption curcumin and BosPure a standardised AKBA-enriched boswellia. Using documented branded materials rather than commodity powder is verifiable from the label and is the basis for Curamin's strong reputation as a multi-pathway formula.
Targets multiple inflammatory pathways for comprehensive pain relief.
Mechanistically accurate: boswellia inhibits 5-LOX (leukotriene pathway) while curcumin acts mainly through NF-κB. These are genuinely distinct, non-overlapping arms of the inflammatory cascade, so the multi-pathway framing is real — this is the central, legitimate reason to buy a combo over a single ingredient.
The #1 selling brand of curcumin in the natural channel.
Terry Naturally / BCM-95 is indeed a leading curcumin brand in the natural-products channel with strong sales standing, but sales-rank superlatives shift over time and aren't independently auditable in real time. The brand's prominence is real; treat the exact "#1" framing as marketing rather than a fixed verified fact.
Stops pain without the risks of NSAIDs.
Directionally fair — boswellia and curcumin relieve inflammation through non-COX mechanisms, avoiding the GI and cardiovascular profile of chronic NSAID use. But "stops pain" overstates a botanical's effect size; the trials show meaningful symptom reduction, not NSAID-equivalent analgesia for everyone. Honest about mechanism, optimistic about magnitude.
What Our Test Actually Found
Curamin is NOT CuraMed — get the right bottle
The single most common mistake with this product is buying the wrong Terry Naturally formula. CuraMed is curcumin-only (BCM-95, single active). Curamin — the one reviewed here — is the multi-ingredient pain formula: BCM-95 curcumin PLUS BosPure boswellia, DLPA, and nattokinase. The names differ by two letters and the bottles look similar. If you specifically want the boswellia-plus-curcumin two-pathway combination, you must buy Curamin; CuraMed will give you curcumin alone. Double-check the label before you order.
The two-pathway logic is the entire reason this exists
Curamin isn't a gimmick combo — it's mechanism-driven. Boswellia inhibits 5-LOX (the leukotriene branch); curcumin works mainly through NF-κB (a broad inflammatory-signalling hub). These pathways don't overlap, so hitting both covers more of the inflammation problem than either alone. That's the same reasoning that makes boswellia worth stacking with omega-3. Curamin packages that stack into one bottle with branded standardised actives, which is why it's so well-reviewed for stubborn pain. If you understand and want the two-pathway approach, this is the cleanest single-bottle execution of it.
You're trading dose control for convenience
The cost of putting boswellia and curcumin in one tablet is that you can't tune them independently. With separate bottles you could run, say, a high boswellia dose with a modest curcumin dose, or vice versa, to match your response. Curamin fixes the ratio for you. For most buyers that's fine — the formula's ratio is sensibly designed — but if you're the kind of user who titrates each input, separate bottles (Swanson #5 plus a dedicated high-absorption curcumin) give you control that Curamin deliberately trades away for simplicity.
It's the most expensive pick — and that's only worth it for the right buyer
At ~$40/month and a one-month supply per bottle, Curamin is the priciest product on this list by a wide margin. That price is defensible IF you'd otherwise buy both a good boswellia and a good high-absorption curcumin separately — the combined cost is comparable and you save managing two bottles. But if you only want boswellia, you're paying for a curcumin dose you didn't ask for, and NOW (#4) at $11 is the rational buy. The value verdict hinges entirely on whether you genuinely want both actives.
The DLPA is a feature for some buyers and a reason to skip for others
Curamin includes DLPA (DL-phenylalanine), a long-standing ingredient in natural pain formulas thought to support the body's own pain-modulating pathways. Most people tolerate it fine. But it's a co-ingredient some buyers actively don't want — people with PKU must avoid phenylalanine, and anyone on MAOIs or with blood-pressure considerations should check with a clinician first. If you want pure boswellia-plus-curcumin without the extra amino acid, separate bottles let you build that exact stack. It's not a flaw, but it is a fork in the decision.
Full analysis: all pros & cons (8), buy if / skip if
- Combines boswellia (5-LOX) and curcumin (NF-κB) — two complementary anti-inflammatory pathways in one product
- Uses branded standardised actives (BosPure boswellia, BCM-95 curcumin) rather than commodity powder
- One of the best-reviewed natural pain formulas on the market for stubborn joint pain
- Saves stacking two separate bottles if you genuinely want both mechanisms
- Sensible morning/evening split dosing with branded, documented materials
- Most expensive pick on the list at the full 4-tablet daily dose (~$40/month, one-month supply)
- Combination format means you can't tune the boswellia and curcumin doses independently
- Contains DLPA — fine for most, but a co-ingredient some buyers don't want or need
- You're already convinced you want both boswellia and curcumin and would rather take one bottle
- You have stubborn osteoarthritis or chronic joint pain and want the strongest natural multi-pathway formula
- You want branded standardised actives (BosPure, BCM-95) rather than commodity boswellia and curcumin powder
- You'd otherwise buy a good boswellia and a good high-absorption curcumin separately anyway
- You're a first-time boswellia buyer testing whether it helps you — start with NOW (#4) or Swanson (#5)
- You're on a tight budget — at $40/month it's the most expensive pick on the list
- You want to dose boswellia and curcumin independently, or you don't want the DLPA co-ingredient
BosPure boswellia (5-LOX) + BCM-95 curcumin (NF-κB) + DLPA — two complementary inflammatory pathways in a single, well-reviewed pain formula using standardised branded actives, not commodity powder. The cleanest way to run boswellia and curcumin together without managing two bottles. The catches: it's the most expensive pick on the list at the 4-tablet dose, you can't dose the two components independently, and it's overkill if you only want boswellia.
Terry Naturally Curamin is the pick for the buyer who's already decided they want both boswellia and curcumin — and if you understand the mechanism, you probably should. The two work on different arms of inflammation: boswellia inhibits 5-lipoxygenase (5-LOX), blocking leukotrienes, while curcumin acts mainly through NF-κB, damping a broad set of inflammatory signals. They don't overlap, so they stack. Curamin combines them in one bottle using branded standardised actives — BosPure boswellia and BCM-95 high-absorption curcumin — plus DLPA, which is why it's consistently one of the best-reviewed natural pain formulas on the market. The trade-offs are real: it's the most expensive pick on this list at the full four-tablet daily dose, and the combination format means you can't tune the boswellia and curcumin amounts independently. One important note before you buy — Curamin is NOT the same as CuraMed, Terry Naturally's curcumin-only product. Here's the full breakdown.
The right pick if you genuinely want both pathways — overkill if you don't.
Terry Naturally Curamin is the cleanest single-bottle way to run boswellia and curcumin together, and for the buyer who wants that, it's arguably the best natural multi-pathway pain formula on the market. The mechanism logic is sound (5-LOX plus NF-κB, two non-overlapping arms of inflammation), the actives are branded and standardised (BosPure, BCM-95), and the formula is well-reviewed for stubborn osteoarthritis. If you'd otherwise buy a good boswellia and a good high-absorption curcumin separately, Curamin's price is competitive and it saves you managing two bottles. But match the product to the use case. This is NOT the pick for a first-time boswellia buyer testing whether the supplement helps — that's NOW (#4) or Swanson (#5) at a third of the price. It's the most expensive product on the list, you can't dose the two components independently, and the DLPA co-ingredient isn't for everyone. And don't confuse it with CuraMed (curcumin-only). For the stubborn-pain buyer who wants both mechanisms in one branded bottle, it's excellent; for anyone else, it's more product than the job needs.
If This Doesn’t Fit — Try These
04NOW Boswellia Extract
A solid budget bottle that does two jobs: a standardised boswellia extract and a real turmeric dose (200 mg of 95%-curcuminoid extract plus 200 mg of powder per two caps), made under NOW's reliable QC for about $11.
01Life Extension Boswellia
If you want a named, AKBA-enriched extract at exactly the dose it was tested at, this is the bottle.
03Pure Encapsulations Boswellia
If you have a sensitive gut, react to fillers, or simply want the most transparent label available, Pure Encapsulations is the pick.
Quick Answers
Is Curamin the same as CuraMed?
No — and the names are confusingly similar, so this trips people up. CuraMed is Terry Naturally's curcumin-only product (BCM-95 curcumin, single active). Curamin — the one reviewed here — is the multi-ingredient pain formula: BCM-95 curcumin PLUS BosPure boswellia, DLPA, and nattokinase. If you want both the boswellia (5-LOX) and curcumin (NF-κB) pathways in one bottle, Curamin is the one. If you only want curcumin, CuraMed is the simpler, cheaper buy. They're made by the same brand with the same flagship curcumin, but they are not interchangeable products.
Why combine boswellia and curcumin instead of taking them separately?
Because they hit different arms of the inflammatory cascade and complement each other. Boswellia inhibits 5-lipoxygenase (5-LOX), blocking leukotrienes; curcumin acts mainly through NF-κB, damping a broad set of inflammatory signals. Neither pathway fully overlaps the other, so combining them covers more of the inflammation problem than either alone — the same logic behind stacking boswellia with omega-3. Curamin does this with branded standardised actives (BosPure, BCM-95) rather than commodity powder, which is why it's one of the best-reviewed natural pain formulas on the market. The trade-off is that you can't tune the two doses independently the way you could with separate bottles.
What's the daily dose, and why 4 tablets?
The standard Curamin dose is 4 tablets a day, typically split (two morning, two evening with food). It's four tablets because the formula packs meaningful doses of both BCM-95 curcumin and BosPure boswellia plus the co-ingredients into each serving — getting clinical-range amounts of two standardised actives takes more tablet mass than a single-ingredient product. You can start at two tablets to assess tolerance, but the full four-tablet dose is where the formula is designed to work. At four a day the 120-tablet bottle is a one-month supply, which is part of why it's the most expensive pick on the list.
What is the DLPA in Curamin for, and do I need to worry about it?
DLPA (DL-phenylalanine) is an amino acid included for its role in supporting the body's own pain-modulating pathways — it's a long-standing ingredient in natural pain formulas. For most people it's well tolerated and unremarkable. The caveats worth knowing: people with PKU (phenylketonuria) must avoid phenylalanine entirely, and anyone on MAOI antidepressants or with certain blood-pressure considerations should check with a clinician before taking DLPA-containing products. It's a co-ingredient some buyers simply don't want or need — if you'd rather have boswellia and curcumin without DLPA, separate bottles (Swanson #5 plus a dedicated curcumin) give you that control.
Is Curamin worth $40 a month when NOW Boswellia is $11?
It depends on what you're buying. NOW (#4) is a budget whole extract with plain turmeric; Curamin is two standardised, branded actives (boswellia plus a high-absorption curcumin) in one formula. If you'd otherwise buy both a good boswellia and a good high-absorption curcumin separately, Curamin's $40 is competitive with the combined cost and saves you managing two bottles. If you only want boswellia, Curamin is overkill — you're paying for a curcumin dose you didn't need, and NOW at $11 is the rational buy. The honest framing: Curamin is a premium two-pathway pain formula, not a boswellia value pick.
Who is Curamin actually the best choice for?
Someone with stubborn osteoarthritis or chronic joint pain who's already convinced they want both boswellia and curcumin, wants branded standardised actives rather than commodity powder, and would rather take one bottle than three. For that buyer it's arguably the single best natural multi-pathway pain formula on the market. It's NOT the right pick for a first-time boswellia buyer testing whether the supplement helps them (start with NOW #4 or Swanson #5), for someone on a tight budget, or for anyone who wants to dose boswellia and curcumin independently. Match the product to the use case and it's excellent; buy it as a generic boswellia bottle and you've overspent.
Sources & Further Reading
2 peer-reviewed sources, each linked to PubMed
- [1] Kimmatkar 2003 PMID 12622457 — Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — a randomized double blind placebo controlled trial. Randomised, double-blind, placebo-controlled crossover trial in knee-osteoarthritis patients: a standardised Boswellia serrata extract significantly reduced knee pain, improved function, and increased walking distance versus placebo over 8 weeks. The efficacy basis for the boswellia (BosPure) half of Curamin's two-pathway formula.
- [2] Sengupta 2008 PMID 18667054 — A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Placebo-controlled trial of AKBA-enriched Boswellia extract (5-Loxin, ~30% AKBA) at 100 and 250 mg/day in knee osteoarthritis: significant, dose-related pain and function improvements, with relief within ~7 days at 250 mg. Establishes the AKBA-enrichment standard that Curamin's BosPure boswellia targets.
Affiliate disclosure: every Amazon link uses our Associates tag (superachieverclub-20). We earn a small commission at no cost to you; it funds independent reviews. We never accept payment to change a ranking.